Using Radiation Therapy to Prime and Propagate an Anti-tumor Immune Response Against Brain Tumors

[1]  Amy K. Erbe,et al.  Tumor-Specific Antibody, Cetuximab, Enhances the In Situ Vaccine Effect of Radiation in Immunologically Cold Head and Neck Squamous Cell Carcinoma , 2020, Frontiers in Immunology.

[2]  A. Bates,et al.  Abstract 2256: Low dose brain radiotherapy enhances the efficacy of an extracranialin situvaccine regimen against melanoma brain metastases in a pre-clinical murine model , 2020 .

[3]  KyungMann Kim,et al.  In situ vaccination at a peripheral tumor site augments response against melanoma brain metastases , 2020, Journal for ImmunoTherapy of Cancer.

[4]  C. Brennan,et al.  Interrogation of the Microenvironmental Landscape in Brain Tumors Reveals Disease-Specific Alterations of Immune Cells , 2020, Cell.

[5]  Z. Morris,et al.  Priming and Propagating Anti-tumor Immunity: Focal Hypofractionated Radiation for in Situ Vaccination and Systemic Targeted Radionuclide Theranostics for Immunomodulation of Tumor Microenvironments. , 2020, Seminars in radiation oncology.

[6]  S. Ryu,et al.  Repolarized macrophages, induced by intermediate stereotactic dose radiotherapy and immune checkpoint blockade, contribute to long-term survival in glioma-bearing mice , 2020, Journal of Neuro-Oncology.

[7]  J. Sampson,et al.  Brain immunology and immunotherapy in brain tumours , 2019, Nature Reviews Cancer.

[8]  J. Aerts,et al.  Effect of Pembrolizumab After Stereotactic Body Radiotherapy vs Pembrolizumab Alone on Tumor Response in Patients With Advanced Non-Small Cell Lung Cancer: Results of the PEMBRO-RT Phase 2 Randomized Clinical Trial. , 2019, JAMA oncology.

[9]  L. Sevenich.  Turning “Cold” Into “Hot” Tumors—Opportunities and Challenges for Radio-Immunotherapy Against Primary and Metastatic Brain Cancers , 2019, Front. Oncol..

[10]  P. Blinder,et al.  Prophylactic TLR9 stimulation reduces brain metastasis through microglia activation , 2019, bioRxiv.

[11]  R. Emerson,et al.  Radiotherapy induces responses of lung cancer to CTLA-4 blockade , 2018, Nature Medicine.

[12]  M. Atkins,et al.  Combined Nivolumab and Ipilimumab in Melanoma Metastatic to the Brain , 2018, The New England journal of medicine.

[13]  P. Harari,et al.  Tumor-Specific Inhibition of In Situ Vaccination by Distant Untreated Tumor Sites , 2018, Cancer Immunology Research.

[14]  A. Melcher,et al.  Anti–PD-1/anti–CTLA-4 efficacy in melanoma brain metastases depends on extracranial disease and augmentation of CD8+ T cell trafficking , 2018, Proceedings of the National Academy of Sciences.

[15]  L. Galluzzi,et al.  Emerging biomarkers for the combination of radiotherapy and immune checkpoint blockers. , 2017, Seminars in cancer biology.

[16]  S. Formenti,et al.  Previous radiotherapy and the clinical activity and toxicity of pembrolizumab in the treatment of non-small-cell lung cancer: a secondary analysis of the KEYNOTE-001 phase 1 trial. , 2017, The Lancet. Oncology.

[17]  C. N. Coleman,et al.  DNA exonuclease Trex1 regulates radiotherapy-induced tumour immunogenicity , 2017, Nature Communications.

[18]  P. Harari,et al.  In Situ Tumor Vaccination by Combining Local Radiation and Tumor-Specific Antibody or Immunocytokine Treatments. , 2016, Cancer research.

[19]  H. Ishwaran,et al.  Radiation and Dual Checkpoint Blockade Activates Non-Redundant Immune Mechanisms in Cancer , 2015, Nature.

[20]  P. Pickhardt,et al.  Alkylphosphocholine Analogs for Broad-Spectrum Cancer Imaging and Therapy , 2014, Science Translational Medicine.

[21]  A. Balogh,et al.  The effect of ionizing radiation on the homeostasis and functional integrity of murine splenic regulatory T cells , 2013, Inflammation Research.

[22]  S. Demaria,et al.  Radiation therapy to convert the tumor into an in situ vaccine. , 2012, International journal of radiation oncology, biology, physics.

[23]  R. Ransohoff,et al.  Innate immunity in the central nervous system. , 2012, The Journal of clinical investigation.

[24]  N. Kawashima,et al.  The Combination of Ionizing Radiation and Peripheral Vaccination Produces Long-term Survival of Mice Bearing Established Invasive GL261 Gliomas , 2006, Clinical Cancer Research.